-
Something wrong with this record ?
Edible marine algae: a new source for anti-mycobacterial agents
G. Mukherjee, B. Mukhopadhyay, AK. Sil
Language English Country United States
Document type Journal Article
- MeSH
- Anti-Bacterial Agents isolation & purification pharmacology MeSH
- Biofilms drug effects MeSH
- Cell Line MeSH
- Isoniazid pharmacology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Seaweed chemistry MeSH
- Mycobacterium smegmatis drug effects MeSH
- Rifampin pharmacology MeSH
- Plant Extracts isolation & purification pharmacology MeSH
- Drug Synergism MeSH
- Ulva chemistry MeSH
- Cell Survival MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Tuberculosis is a dreaded disease, which causes innumerable death worldwide. The emergence of drug resistance strains makes the situation devastating. Therefore, for better management of public health, it is mandatory to search for new anti-mycobacterial agents. In this context, the current study investigated two edible marine algae, Ulva lactuca and Ulva intestinalis, for the probable source of new anti-mycobacterial agents. To test the anti-mycobacterial activity, alcoholic extracts of these two algae were spotted on the Mycobacterium smegmatis lawn. Upon incubation, clear zone was observed at the spots. It indicated that these two extracts have anti-mycobacterial activity. In addition, their anti-biofilm property was also tested. It was found that both the extracts inhibit the mycobacterial biofilm development as well as they can disperse the preformed mycobacterial biofilm. Since these two are capable of dispersing preformed mycobacterial biofilm, it is possible that in the presence of either of these two extracts, isoniazid and rifampicin can kill biofilm encapsulated mycobacterium in combinatorial therapy. Consistent with the hypothesis, rifampicin and isoniazid killed mycobacteria that were present in biofilm. Thus, these two extracts augment the activity of rifampicin and isoniazid upon biofilm dispersal. Moreover, treatment of different cell lines with these two extracts exhibited no or little cytotoxic effects. Thus, these two agents have the potential to be good therapeutic agents against mycobacterial diseases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21022228
- 003
- CZ-PrNML
- 005
- 20210902094739.0
- 007
- ta
- 008
- 210902s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-020-00823-3 $2 doi
- 035 __
- $a (PubMed)32975727
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mukherjee, Goutam $u Department of Microbiology, University of Calcutta, Kolkata, West Bengal, India
- 245 10
- $a Edible marine algae: a new source for anti-mycobacterial agents / $c G. Mukherjee, B. Mukhopadhyay, AK. Sil
- 520 9_
- $a Tuberculosis is a dreaded disease, which causes innumerable death worldwide. The emergence of drug resistance strains makes the situation devastating. Therefore, for better management of public health, it is mandatory to search for new anti-mycobacterial agents. In this context, the current study investigated two edible marine algae, Ulva lactuca and Ulva intestinalis, for the probable source of new anti-mycobacterial agents. To test the anti-mycobacterial activity, alcoholic extracts of these two algae were spotted on the Mycobacterium smegmatis lawn. Upon incubation, clear zone was observed at the spots. It indicated that these two extracts have anti-mycobacterial activity. In addition, their anti-biofilm property was also tested. It was found that both the extracts inhibit the mycobacterial biofilm development as well as they can disperse the preformed mycobacterial biofilm. Since these two are capable of dispersing preformed mycobacterial biofilm, it is possible that in the presence of either of these two extracts, isoniazid and rifampicin can kill biofilm encapsulated mycobacterium in combinatorial therapy. Consistent with the hypothesis, rifampicin and isoniazid killed mycobacteria that were present in biofilm. Thus, these two extracts augment the activity of rifampicin and isoniazid upon biofilm dispersal. Moreover, treatment of different cell lines with these two extracts exhibited no or little cytotoxic effects. Thus, these two agents have the potential to be good therapeutic agents against mycobacterial diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x izolace a purifikace $x farmakologie $7 D000900
- 650 _2
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a viabilita buněk $7 D002470
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a isoniazid $x farmakologie $7 D007538
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Mycobacterium smegmatis $x účinky léků $7 D020102
- 650 _2
- $a rostlinné extrakty $x izolace a purifikace $x farmakologie $7 D010936
- 650 _2
- $a rifampin $x farmakologie $7 D012293
- 650 _2
- $a mořské řasy $x chemie $7 D012624
- 650 _2
- $a Ulva $x chemie $7 D044445
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mukhopadhyay, Balaram $u Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, India
- 700 1_
- $a Sil, Alok Kumar $u Department of Microbiology, University of Calcutta, Kolkata, West Bengal, India. alokksil7@gmail.com
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 66, č. 1 (2021), s. 99-105
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32975727 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210902 $b ABA008
- 991 __
- $a 20210902094736 $b ABA008
- 999 __
- $a ok $b bmc $g 1692551 $s 1142702
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 66 $c 1 $d 99-105 $e 20200925 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20210902